Not actual patient.
Not an actual patient.
Not an actual patient.
Eczema affects an estimated 7.2% of adults and 10.7% of children in the US. Nearly half of all cases begin in the first 6 months of life, and 90% occur by age 5.
A mid-strength topical steroid that could help treat your symptoms with few side effects.
Significant improvement of redness, blisters, scaling, crusting, and hardened or leathery skin by the 4th day of treatment.
The active ingredient (clocortolone pivalate) dissolves into oils readily, enabling it to absorb into the skin.
Available in 45 g and 90 g tubes, as well as 75 g pump.
A Group C corticosteroid, it exhibits the lowest potential risk for allergic contact dermatitis induced by a topically applied corticosteroid.
Active Ingredient
Clocortolone pivalate
| Key Ingredients | NO |
|---|---|
| White petrolatum | NO Lanolin |
| Mineral oil | NO Propylene glycol |
| Stearyl alcohol | NO Added fragrance |
Not an actual patient.
A Group C corticosteroid, it exhibits the lowest potential risk for allergic contact dermatitis induced by a topically applied corticosteroid.
Active Ingredient
Clocortolone pivalate
| Key Ingredients | NO |
|---|---|
| White petrolatum | NO Lanolin |
| Mineral oil | NO Propylene glycol |
| Stearyl alcohol | NO Added fragrance |
Indicated to treat symptoms of eczema in pediatric and adult patients.*
Including sensitive areas such as the face and skin fold areas like the armpit or behind the knee.
In a study measuring treatment success:
For more information about safety and side effects of CLODERM Cream, please see Full Prescribing Information and talk to your doctor.
*Parents of pediatric patients should not use tight-fitting diapers or plastic pants on a child being treated in the diaper area, as these garments may constitute occlusive dressings.
Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing’s syndrome than mature patients because of a larger skin surface area to body weight ratio. Administration of topical corticosteroids to children should be limited to the least amount compatible with an effective therapeutic regimen.
What is CLODERM Cream?
CLODERM Cream has an active ingredient, clocortolone pivalate, that enables it to provide fast and effective treatment with few side effects.
Where can I use CLODERM Cream?
CLODERM Cream can be used on most areas of the body. This includes sensitive areas such as the face and skin fold areas like the armpit or behind the knee. Avoid contact with the eyes and mouth, and intravaginal use.
How safe is CLODERM Cream?
In multiple clinical studies, there were few side effects, none of them serious.
Infrequent side effects listed in decreasing order include: burning, itching, irritation, dryness, inflamed hair follicles, abnormal hair growth, and acne-like eruptions.
For more about the safety of CLODERM Cream, see the Full Prescribing Information.
How much CLODERM Cream should I use?
The amount of CLODERM Cream to be applied will depend on the size and location of the affected area. CLODERM Cream is available in a pump for precise treatment of specific areas, and in tubes for covering larger areas. Your doctor will prescribe either a pump or a tube, and advise you on how to use it. In all cases, apply only a thin layer to the affected area.
How much CLODERM Cream should be used on a child?
The amount of CLODERM Cream to be applied will depend on the size and location of the affected area. The doctor will prescribe either a pump or a tube, and provide advice on how it should be used. In all cases, apply only a thin layer to the affected area.
APPROVED USE
CLODERM Cream, 0.1% is indicated for the relief of the inflammatory and itching symptoms of corticosteroid responsive skin diseases.
IMPORTANT PATIENT SAFETY INFORMATION
Children may absorb proportionally larger amounts of topical corticosteroids and may be more susceptible to side effects. As with all topical corticosteroids, too much CLODERM Cream passing through your skin can cause your adrenal glands to stop working. Your healthcare provider may do blood tests to check for adrenal gland problems.
The most common side effects of CLODERM Cream include burning, itching, irritation, dryness, inflamed hair follicles (folliculitis), excessive hair growth, acne-like eruptions, and thinning of the skin with prolonged use.
These are not all the possible side effects of CLODERM Cream. For more information, ask your healthcare provider or pharmacist.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/Safety/MedWatch or call 1-800-FDA-1088.
Click here to see Full Prescribing Information.
References: 1. Cloderm [package insert]. Charleston, SC: EPI Health, LLC; 2018. 2. Rosenthal AL. Clocortolone pivalate: a paired comparison clinical trial of a new topical steroid in eczema/atopic dermatitis. Cutis. 1980;25(1):96-98. 3. Del Rosso JQ, Kircik L. A comprehensive review of clocortolone pivalate 0.1% cream: structural development, formulation characteristics, and studies supporting treatment of corticosteroid-responsive dermatoses. J Clin Aesthet Dermatol. 2012;5(7):20-24. 4. Kircik LH. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay. J Drugs Dermatol. 2014;13(5):582-585. 5. Bikowski J, Pillai R, Shroot B. The position not the presence of the halogen in corticosteroids influences potency and side effects. J Drugs Dermatol. 2006;5(2):125-130. 6. Katz M, Gans EH. Topical corticosteroids, structure-activity and the glucocorticoid receptor: discovery and development—a process of ‘‘planned serendipity.’’ J Pharm Sci. 2008;97(8):2936-2947. 7. Jacob SE, Steele T. Corticosteroid classes: A quick reference guide including patch test substances and cross-reactivity. J Am Acad Dermatol. 2006;54(4):723-727. 8. Nierman MM. Safety and efficacy of clocortolone pivalate 0.1 percent cream in the treatment of atopic dermatitis, contact dermatitis, and seborrheic dermatitis. Cutis. 1981;27(6):670-671. 9. Kircik LH, Del Rosso JQ. The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream. J Drugs Dermatol. 2012;11(10):1194-1198.
IMPORTANT PATIENT SAFETY INFORMATION
You are about to leave the Cloderm product website.
EPI Health does not administer the information on the linked website,
and does not monitor or endorse the information.
This link solely provides additional information that may help you
locate and identify other Internet resources that may be of interest.
